PhRMA cosponsors health policy conference series
Rising rates of chronic medical conditions is the topic of a July 31 conference convened by the Center for Studying Health System Change and sponsored by the Pharmaceutical Research and Manufacturers of America, the American College of Preventive Medicine and DMAA: The Care Continuum Alliance. Chronic illness was the theme of PhRMA's most recent annual meeting (1"The Pink Sheet," April 7, 2008, p. 15). The upcoming session, to be held in Washington, D.C. will consider the growing prevalence of chronic health conditions, and resulting costs, consequences and need for preventive strategies. It is the first of four policy conferences; future topics include value-based health benefit structures
You may also be interested in...
DANA POINT, Calif. - A mood of resolute pride saturated the 50th annual meeting of the Pharmaceutical Research and Manufacturers of America, where speakers and panelists stressed the industry's eventual return to its once-bright public image by spreading the news about what they said is the biggest factor pushing up costs of medical care in the developed world: treatment of chronic diseases, especially those caused by obesity
Cipla has expanded its partnership with Alvotech to cover the commercialization of five biosimilars in Australia and New Zealand, building on an existing alliance covering South Africa and emerging markets.
Lack of official explanation about how the exchange of critical information will progress pending the launch of the EU’s medical device database, Eudamed3, has left many confused. New guidance lights the way forward.